Sichuan Academy Of Medical Sciences
Clinical trials sponsored by Sichuan Academy Of Medical Sciences, explained in plain language.
-
New eye drop trial aims to slow diabetic eye damage
Disease control Not yet recruitingThis very early study will test NPDR-01 eye drops in 10 people with non-proliferative diabetic retinopathy, a common diabetes-related eye condition. The goal is to see if the drops can reduce tiny, leaky blood vessels in the retina (microaneurysms) and slow the disease's progress…
Phase: EARLY_PHASE1 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Common supplement could help control MS symptoms
Disease control Not yet recruitingThis study is testing whether adding taurine supplements to standard multiple sclerosis medications helps control the disease better. Researchers will follow 80 adults with MS for two years to see if taurine reduces new brain lesions, lowers relapse rates, and slows disability pr…
Phase: PHASE2 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC